How the latest biotech IPO targets faster, better drug development
September 27, 2018 at 17:43 PM EDT
The company's stock rose a modest 20 cents Thursday from its $15 IPO price.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|